Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in active primary Sjogren's syndrome
NCT04916756Phase 2Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib, sponsored by Peking Union Medical College Hospital. Started Jan 2020; status: completed.
02
Drugs
baricitinib
Beyond the preview
Go deeper on NCT04916756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04916756.